HomeRGNT • NYSEAMERICAN
add
Regentis Biomaterials Ltd
Previous close
$3.35
Day range
$3.20 - $3.32
Year range
$3.10 - $8.35
Market cap
16.80M USD
Avg Volume
19.40K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.26M | 593.84% |
Net income | -5.21M | -333.08% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.38M | 3,121.83% |
Total assets | 7.62M | 1,480.50% |
Total liabilities | 2.87M | -55.70% |
Total equity | 4.74M | — |
Shares outstanding | 5.18M | — |
Price to book | 3.64 | — |
Return on assets | -107.13% | — |
Return on capital | -137.37% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -5.21M | -333.08% |
Cash from operations | -517.50K | -59.97% |
Cash from investing | — | — |
Cash from financing | 4.11M | 1,074.86% |
Net change in cash | 3.59M | 13,464.15% |
Free cash flow | 1.58M | 828.47% |
About
Founded
2004
Website
Employees
6
